← Leaderboards
Ilia Fishbein
Children'S Hosp Of Philadelphia
$3,426,991
Attributed
$6,853,981
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2013–20$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$6,853,981 · 4
By mechanism
R01$6,224,606 · 2
R56$420,000 · 1
R21$209,375 · 1
Top collaborators
- Robert J Levy5 shared
- Stanley Joseph Stachelek5 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Robert J Levy$36,673,646
- Michael Chorny$5,184,479
- Stanley Joseph Stachelek$1,791,630
- Osheiza Y Abdulmalik$2,011,163
- Fanxin Long$15,863,543
Others in their field
Top investigators on “Metals”
- Robert O Wright · Brigham And Women'S Hospital$62,962,765
- Max Costa · New York University School Of Medicine$41,359,995
- Margaret Rita Karagas · Dartmouth College$36,951,051
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$36,318,183
- David R. Weir · University Of Michigan At Ann Arbor$33,004,619
- Christina Trahan Cain · Center For Construction Res And Training$32,955,791
Research focus
MetalsAnimalsInflammationRestenosisTherapeutic StudiesSurfaceSiteArteriesProgramsIn VivoStentsPharmaceutical PreparationsPreclinical StudyPathogenesisPreventLaboratoriesFamily SuidaeAmino AcidsFunctional DisorderDesignInflammatoryCoronaryDiabeticCarotid Stent
Grant awards (10)
Oxidation Resistant ApoA1 Gene Delivery Stents$823,802
R01 · FY2020 · HL
Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies$708,407
R01 · FY2020 · EB
Oxidation Resistant ApoA1 Gene Delivery Stents$828,102
R01 · FY2019 · HL
Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies$720,017
R01 · FY2019 · EB
Oxidation Resistant ApoA1 Gene Delivery Stents$832,402
R01 · FY2018 · HL
Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies$720,017
R01 · FY2018 · EB
Oxidation Resistant ApoA1 Gene Delivery Stents$853,842
R01 · FY2017 · HL
Increasing biocompatibility of stents via CD47 surface functionalization: Mechanistic and Preclinical studies$738,017
R01 · FY2017 · EB
Gene Delivery Stents AAV Formulations$420,000
R56 · FY2015 · HL
Increasing biocompatibility of stents through CD47 functionalization$209,375
R21 · FY2013 · EB